NCT00764621 - Health Economic Evaluation of Primovist-enhanced Liver MRI | Biotech Hunter

Enrollment

360

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

November 30, 2010

Conditions

Colorectal NeoplasmsNeoplasm Metastasis

Interventions

PROCEDURE

Primovist MRI

Contrast-enhanced MRI with an i.v. application of Primovist in the approved dosage

PROCEDURE

Extracellular contrast media (ECCM) MRI

Contrast-enhanced MRI with an i.v. application of an approved extracellular contrast medium in the approved dosage

PROCEDURE

Contrast-enhanced CT

Contrast-enhanced 3 phase multidetector CT with an i.v. application of an approved iodinated contrast medium in the approved dosage

Trial Locations (44)

1030

Vienna

1090

Vienna

1211

Geneva

3010

Bern

4031

Basel

6000

Lucerne

8036

Graz

9007

Sankt Gallen

10060

Candiolo

10117

Berlin

10700

Bangkok

17176

Stockholm

17489

Greifswald

25100

Brescia

38009

Santa Cruz de Tenerife

39112

Magdeburg

40138

Bologna

41013

Seville

44137

Dortmund

44263

Dortmund

60126

Ancona

60596

Frankfurt am Main

66100

Chieti

72076

Tübingen

75185

Uppsala

76133

Karlsruhe

80138

Napoli

81377

München

81675

München

90110

Songkhla

519809

Hwasun

01067

Dresden

1066CX

Amsterdam

2333 ZA

Leiden

3584 CX

Utrecht

152-703

Seoul

463-707

Gyeunggi-do

561-712

Jeonbuk

110-744

Seoul

135-710

Seoul

138-736

Seoul

Unknown

Seoul

08036

Barcelona

182 88

Stockholm